ENZO BIOCHEM INC (ENZ) Stock Analyst Earnings Estimates
NYSE:ENZ - New York Stock Exchange, Inc. - US2941001024 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | ||
|---|---|---|---|---|
| Revenue YoY % growth | 32.643M -72.27% | 31.061M -4.85% | 31.907M 2.72% | |
| EBITDA YoY % growth | -9.265M -214.77% | -16.858M -81.95% | -8.461M 49.81% | |
| EBIT YoY % growth | -12.092M -323.10% | -19.54M -61.59% | -9.733M 50.19% | |
| Operating Margin | -37.04% | -62.91% | -30.50% | |
| EPS YoY % growth | -0.27 | N/A | N/A |
All data in USD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2022 Q2Q % growth | -0.17 -342.86% | % | ||
| Q3 2022 Q2Q % growth | -0.09 -325.00% | % | ||
| Q2 2022 Q2Q % growth | 0.03 -66.67% | % | ||
| Q1 2022 Q2Q % growth | -0.04 -500.00% | % | ||
| Q4 2021 Q2Q % growth | 0.07 200.59% | % | ||
| Q3 2021 Q2Q % growth | 0.04 119.05% | % | ||
| Q2 2021 Q2Q % growth | 0.09 156.25% | % | ||
| Q3 2020 Q2Q % growth | -0.21 -50.00% | % | ||
| Q2 2020 Q2Q % growth | -0.16 11.11% | % | ||
| Q3 2019 Q2Q % growth | -0.14 | -0.15 | 0.01 | 7.59% |
| Q2 2019 Q2Q % growth | -0.18 | -0.13 | -0.05 | -37.09% |
| Q1 2019 Q2Q % growth | -0.13 | -0.11 | -0.02 | -17.01% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 6.213M -20.41% | % | ||
| Q4 2024 Q2Q % growth | 7.526M -75.77% | % | ||
| Q3 2024 Q2Q % growth | 8.022M -50.20% | % | ||
| Q2 2024 Q2Q % growth | 8.553M -47.65% | % | ||
| Q1 2024 Q2Q % growth | 7.806M -57.29% | % | ||
| Q4 2023 Q2Q % growth | 31.061M 53.13% | % | ||
| Q3 2023 Q2Q % growth | 16.107M -38.57% | % | ||
| Q2 2023 Q2Q % growth | 16.338M -52.01% | % | ||
| Q1 2023 Q2Q % growth | 18.276M -31.08% | % | ||
| Q4 2022 Q2Q % growth | 20.284M -18.25% | % | ||
| Q3 2022 Q2Q % growth | 26.222M -20.05% | % | ||
| Q2 2022 Q2Q % growth | 34.046M 8.19% | % | ||
| Q1 2022 Q2Q % growth | 26.519M -7.47% | % | ||
| Q4 2021 Q2Q % growth | 24.813M 27.05% | % | ||
| Q3 2021 Q2Q % growth | 32.797M 94.07% | % | ||
| Q2 2021 Q2Q % growth | 31.47M 62.38% | % | ||
| Q1 2021 Q2Q % growth | 28.66M 41.81% | % | ||
| Q4 2020 Q2Q % growth | 19.53M -6.64% | % | ||
| Q3 2020 Q2Q % growth | 16.9M -14.04% | % | ||
| Q2 2020 Q2Q % growth | 19.38M 0.26% | % | ||
| Q1 2020 Q2Q % growth | 20.21M -4.94% | % | ||
| Q3 2019 Q2Q % growth | 19.66M | 19.504M | 156K | 0.80% |
| Q2 2019 Q2Q % growth | 19.33M | 21.217M | -1.887M | -8.89% |
| Q1 2019 Q2Q % growth | 21.26M | 21.332M | -72K | -0.34% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |